SUNFISH: 3-year efficacy and safety of risdiplam in Types 2 and 3 spinal muscular atrophy Goemans, N., Day, J., Deconinck, N., Mazzone, E., Nascimento, A., Oskoui, M., Saito, K., Vuillerot, C., Baranello, G., Boespflug-Tanguy, O., Kirschner, J., Kostera-Pruszczyk, A., Servais, L., Braid, J., Gerber, M., Gorni, K., Martin, C., Scalco, R., Yeung, W., Mercuri, E., SUNFISH Working Grp WILEY. 2022: 278

View details for Web of Science ID 000815254001142